Patient Monitoring Devices | US | 2018 | Market Analysis
Novel monitoring technologies, changes in CMS reimbursement guidelines, and US health demographics will result in a modest expansion of the overall US patient monitoring device market—with the hemodynamic, neurological, and home care monitoring device markets experiencing the most significant growth through 2026.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for patient monitoring devices in the US across a 10-year period.
The installed base of home care monitoring devices will expand significantly through 2026—facilitated by increased reimbursement and adoption of consumer health technology—thereby attracting new players to the market.
How rapidly will patient monitoring devices be adopted for home care patients in the US?
What strategies will new competitors adopt to ensure they successfully penetrate and succeed in the market?
How will new home care monitoring device companies take advantage of lower barriers to entry resulting from the push toward increased connectivity?
How will established competitors react to increased market entry and heightened competitive pressure?
How is consumer technology changing the home care monitoring device market?
Less invasive methods of patient monitoring will increasingly replace invasive techniques in response to the denial of reimbursement for cases of hospital-acquired infections.
To what extent will each market segment be affected by these shifts in monitoring techniques?
How will the preference for less invasive methods drive product adoption in the patient monitoring market?
How can established device manufacturers without experience in patient monitoring take advantage of high-growth market segments?
Will innovations in the market cause system prices to fluctuate over the forecast period?
The importance of connectivity and integration of patient monitoring systems continues to be emphasized by hospitals.
Does US health care policy favor connectivity and integration in this market?
What specific factors are contributing to the desire for integration?
What changes will be seen in the product composition as a consequence?
What are the benefits for companies to partner with or acquire other competitors in the patient monitoring device market as a result of this trend?
